Brigit A. de Jong

4.5k total citations · 1 hit paper
63 papers, 3.2k citations indexed

About

Brigit A. de Jong is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Brigit A. de Jong has authored 63 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 15 papers in Immunology and 11 papers in Neurology. Recurrent topics in Brigit A. de Jong's work include Multiple Sclerosis Research Studies (48 papers), Systemic Lupus Erythematosus Research (7 papers) and Long-Term Effects of COVID-19 (6 papers). Brigit A. de Jong is often cited by papers focused on Multiple Sclerosis Research Studies (48 papers), Systemic Lupus Erythematosus Research (7 papers) and Long-Term Effects of COVID-19 (6 papers). Brigit A. de Jong collaborates with scholars based in Netherlands, United States and United Kingdom. Brigit A. de Jong's co-authors include Walther J. van Venrooij, L B van de Putte, Gerard A. Schellekens, F.H.J. van den Hoogen, T. Huizinga, René E. M. Toes, W J van Venrooij, C. L. Verweij, Suzanne P. Linn-Rasker and F. van Gaalen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Immunology.

In The Last Decade

Brigit A. de Jong

54 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

1998 1.1k citations Gerard A. Schellekens, Brigit A. de Jong et al. Journal of Clinical Investigation profile →

Peers

Brigit A. de Jong

RHEUM

IMMUN

PFM

RNMI

Torsten Witte Germany

David Margolin United States

Andreas Bitsch Germany

Neena Sarkar United States

Gavin Giovannoni United Kingdom

Benjamin Hsu United States

Vesna Brinar Croatia

Alexey Boyко Russia

Jennifer A. Kelly United States

J. S. Wolinsky United States

Torsten Witte Germany

Brigit A. de Jong

1.2k ×0.8

RHEUM

1.3k ×1.4

IMMUN

464 ×0.6

PFM

419 ×0.5

RNMI

376 ×0.7

Citations per year, relative to Brigit A. de Jong Brigit A. de Jong (= 1×) peers Torsten Witte

Countries citing papers authored by Brigit A. de Jong

Since Specialization

Citations

This map shows the geographic impact of Brigit A. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigit A. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigit A. de Jong more than expected).

Fields of papers citing papers by Brigit A. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigit A. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigit A. de Jong. The network helps show where Brigit A. de Jong may publish in the future.

Co-authorship network of co-authors of Brigit A. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Brigit A. de Jong. A scholar is included among the top collaborators of Brigit A. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigit A. de Jong. Brigit A. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beckerman, Heleen, Menno M. Schoonheim, Odile A. van den Heuvel, et al.. (2025). Associations between physical fitness and structural and functional MRI measures in secondary progressive multiple sclerosis: Cross-sectional findings from the exercise PRO-MS study. Multiple Sclerosis and Related Disorders. 97. 106407–106407. 1 indexed citations

Beckerman, Heleen, Tommy A.A. Broeders, Menno M. Schoonheim, et al.. (2025). Effects of 16-week progressive resistance training on neurodegeneration in people with progressive multiple sclerosis: An extended baseline within-person trial. Multiple Sclerosis and Related Disorders. 98. 106411–106411.

Strijbis, Eva, et al.. (2025). Wearing-off symptoms persist in the majority of patients with multiple sclerosis after switching from natalizumab to ocrelizumab. Journal of the Neurological Sciences. 479. 125652–125652.

Jong, Brigit A. de, et al.. (2025). Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment. Journal of Neurology. 272(11). 748–748.

Vanhommerig, Joost W., et al.. (2024). Prevalence and incidence of multiple sclerosis in the Netherlands. Multiple Sclerosis and Related Disorders. 93. 106207–106207. 1 indexed citations

Bosmans, Judith E., Vincent de Groot, Brigit A. de Jong, et al.. (2024). Combining Exercise and Cognitive Training to Postpone Cognitive Decline in People with Multiple Sclerosis: Part of the Don't be late! Study Protocol. Multiple Sclerosis and Related Disorders. 86. 105590–105590.

Meijer, Kim, Brigit A. de Jong, Iman Brouwer, et al.. (2024). Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis. Journal of Neurology. 271(9). 5958–5968.

Damman, Olga C., et al.. (2024). ‘So Let's Go On Like This?’—Shared Decision‐Making and the Use of Outcome Information in Routine Care Management for People With Multiple Sclerosis. Health Expectations. 27(5). e70009–e70009.

Moraal, Bastiaan, Brigit A. de Jong, Bob W. van Oosten, et al.. (2024). Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic. Multiple Sclerosis Journal. 30(13). 1620–1629. 6 indexed citations

10.

Nauta, Ilse M., Tom Fuchs, Brigit A. de Jong, et al.. (2024). Identifying and understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning. Journal of Neurology. 271(5). 2195–2206. 10 indexed citations

11.

Jong, Brigit A. de, Eline A.J. Willemse, Ilse M. Nauta, et al.. (2023). A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort. Journal of Neurology. 270(8). 3851–3861. 13 indexed citations

12.

Vreman, Rick A., Anna Zawada, Magdalena Zielińska, et al.. (2023). Synergy between health technology assessments and clinical guidelines for multiple sclerosis. Clinical and Translational Science. 16(5). 835–849. 6 indexed citations

13.

Visconte, Caterina, María Serpente, Maria Teresa Golia, et al.. (2022). miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis. Cells. 11(9). 1551–1551. 18 indexed citations

14.

Heerings, Marco, Marina Hakobjan, Ward De Witte, et al.. (2022). Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. International Journal of Molecular Sciences. 23(19). 11461–11461. 5 indexed citations

15.

Beckerman, Heleen, Eline A.J. Willemse, Hanneke E. Hulst, et al.. (2022). Brain-derived neurotrophic factor, neurofilament light and glial fibrillary acidic protein do not change in response to aerobic training in people with MS-related fatigue – a secondary analysis of a randomized controlled trial. Multiple Sclerosis and Related Disorders. 70. 104489–104489. 12 indexed citations

16.

Kleerekooper, Iris, Megan K. Herbert, H. Bea Kuiperij, et al.. (2020). CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD. Journal of Neurology Neurosurgery & Psychiatry. 91(6). 605–611. 21 indexed citations

17.

Schellekens, Melanie P. J., et al.. (2017). The Effectiveness of Mindfulness-Based Stress Reduction on Psychological Distress and Cognitive Functioning in Patients with Multiple Sclerosis: a Pilot Study. Mindfulness. 8(5). 1251–1258. 33 indexed citations

18.

Uden, Ingeborg W.M. van, et al.. (2012). Removal of Valproic Acid by Plasmapheresis in a Patient Treated for Multiple Sclerosis. Therapeutic Drug Monitoring. 35(1). 1–3. 11 indexed citations

19.

Jong, Brigit A. de, Rudi G. J. Westendorp, Joyce Eskdale, Bernard M.J. Uitdehaag, & T. Huizinga. (2002). Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Human Immunology. 63(4). 281–285. 46 indexed citations

20.

Schellekens, Gerard A., Brigit A. de Jong, F.H.J. van den Hoogen, L B van de Putte, & Walther J. van Venrooij. (1998). Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.. Journal of Clinical Investigation. 101(1). 273–281. 1086 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact